ArticleActa pharmaceutica Sinica. B2025

Engineered tumor specific AAV for IL-12 delivery in ovarian cancer immunotherapy.

Fan Tong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.